The Clorox Company (NYSE:CLX) Shares Purchased by Advisors Asset Management Inc.

Advisors Asset Management Inc. increased its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 43.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,865 shares of the company's stock after purchasing an additional 9,037 shares during the quarter. Advisors Asset Management Inc.'s holdings in Clorox were worth $4,865,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the stock. Insight Folios Inc lifted its position in shares of Clorox by 3.0% during the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company's stock worth $358,000 after purchasing an additional 63 shares during the last quarter. Fiduciary Group LLC lifted its holdings in Clorox by 0.4% during the 2nd quarter. Fiduciary Group LLC now owns 19,050 shares of the company's stock worth $2,600,000 after buying an additional 72 shares during the last quarter. GHP Investment Advisors Inc. boosted its position in shares of Clorox by 2.0% during the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company's stock worth $496,000 after acquiring an additional 72 shares in the last quarter. SPC Financial Inc. increased its holdings in shares of Clorox by 2.2% in the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company's stock valued at $476,000 after acquiring an additional 75 shares during the last quarter. Finally, Massmutual Trust Co. FSB ADV raised its position in shares of Clorox by 17.2% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company's stock worth $83,000 after acquiring an additional 75 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on CLX shares. TD Cowen raised Clorox from a "sell" rating to a "hold" rating and upped their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Clorox from $144.00 to $151.00 and gave the company a "hold" rating in a research report on Friday, August 2nd. DA Davidson boosted their price target on shares of Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research report on Monday, November 4th. JPMorgan Chase & Co. raised their price objective on Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a report on Friday, October 11th. Finally, Citigroup boosted their target price on Clorox from $165.00 to $170.00 and gave the company a "neutral" rating in a report on Friday, September 6th. Five investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $155.00.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company's stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.57% of the stock is currently owned by corporate insiders.

Clorox Stock Performance

Shares of NYSE CLX traded up $0.15 during mid-day trading on Friday, hitting $169.30. 960,559 shares of the company were exchanged, compared to its average volume of 1,241,732. The stock has a 50 day simple moving average of $162.72 and a 200-day simple moving average of $148.22. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.35. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The firm has a market cap of $20.96 billion, a price-to-earnings ratio of 58.91, a price-to-earnings-growth ratio of 3.11 and a beta of 0.41.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.64 billion. During the same quarter last year, the business earned $0.49 EPS. The business's revenue was up 27.0% on a year-over-year basis. On average, sell-side analysts forecast that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 2.88%. Clorox's dividend payout ratio is currently 170.03%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.